Dimensional Fund Advisors’s Fortress Biotech FBIO Stock Holding History

Dimensional Fund Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,506	Closed	-$84K	–	3315
2017 Q1	$84K	Hold	1,506	–	–	﹤0.01%	3258
2016 Q4	$61K	Sell	1,506 -240	-14%	-$8.97K	﹤0.01%	3262
2016 Q3	$78K	Hold	1,746	–	–	﹤0.01%	3239
2016 Q2	$70K	Hold	1,746	–	–	﹤0.01%	3249
2016 Q1	$81K	Hold	1,746	–	–	﹤0.01%	3242
2015 Q4	$73K	Hold	1,746	–	–	﹤0.01%	3280
2015 Q3	$68K	Hold	1,746	–	–	﹤0.01%	3322
2015 Q2	$88K	Buy	1,746 +873	+100%	+$44.8K	﹤0.01%	3313
2015 Q1	$50K	Buy	+873	New	+$36.4K	﹤0.01%	3309

Other funds holding FBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AHB

Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return

Dimensional Fund Advisors's FBIO Position: Q2 2017 in Review

Dimensional Fund Advisors sold out of Fortress Biotech (FBIO) in Q2 2017, closing a stake of 1,506 shares — an estimated $84K sold.

Dimensional Fund Advisors first reported a position in FBIO in Q1 2015 and held it in 9 quarters. The position peaked at $88K in Q2 2015. 54 funds tracked by Wall St. Rank hold FBIO as of Q2 2017.

Dimensional Fund Advisors reported no remaining Fortress Biotech position as of Q2 2017 after selling out during the quarter.
Dimensional Fund Advisors sold 1,506 Fortress Biotech shares in Q2 2017, an estimated $84K.
Dimensional Fund Advisors first reported a position in Fortress Biotech in Q1 2015 and held it in 9 quarters.
Dimensional Fund Advisors's Fortress Biotech position peaked at $88K in Q2 2015.
54 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2017.

Based on Dimensional Fund Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.